A simple and sensitive HPLC-FL method for bioanalysis of velpatasvir, a novel hepatitis C virus NS5A inhibitor, in rat plasma: Investigation of factors determining its oral bioavailability-Reference-Cited by-同舟云学术

A simple and sensitive HPLC-FL method for bioanalysis of velpatasvir, a novel hepatitis C virus NS5A inhibitor, in rat plasma: Investigation of factors determining its oral bioavailability

Published:2022-10 Issue: Volume:1208 Page:123399
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Choi Eugene,Han Dong-Gyun,Park Jeong-Eun,Lee Ha-Yeon,Yoo Jin-Wook,Jung Yunjin,Song Im-Sook,Yoon In-Soo

Funder

Pusan National University

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference38 articles.

1. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection;Feld;N. Engl. J. Med.,2015

2. Hepatitis C virus NS5A: tales of a promiscuous protein;Macdonald;J. Gen. Virol.,2004

3. Hepatitis C virus NS5A inhibitors and drug resistance mutations;Nakamoto;World J. Gastroenterol.,2014

4. NS5A-from obscurity to new target for HCV therapy;Schmitz;Recent Pat. Antiinfect Drug Discov.,2008

5. Patent highlights: Recently approved HCV NS5A drugs;Hughes;Org. Process Res. Dev.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A simple and sensitive high‐performance liquid chromatographic method combined with fluorescence detection for bioanalysis of scopoletin in rat plasma: Application to a pharmacokinetic study;Biomedical Chromatography;2024-07-22

2. Electrochemical Sensor Modified with Graphene Oxide Decorated with Copper Oxide Nanoparticles for Velpatasvir’s Monitoring in Spiked Human Plasma;Journal of The Electrochemical Society;2024-05-01

3. Physicochemical characterization and phase II metabolic profiling of echinochrome A, a bioactive constituent from sea urchin, and its physiologically based pharmacokinetic modeling in rats and humans;Biomedicine & Pharmacotherapy;2023-06

4. Investigation of the factors responsible for the low oral bioavailability of alizarin using a sensitive LC‐MS/MS method: In vitro, in situ, and in vivo evaluations;Drug Development Research;2023-02-22